I live with both idiopathic pulmonary hypertension (PH) and scleroderma, and earlier this month, I was taught a lesson in how quickly things can unravel when you’re with people who are well-versed in one condition while you’re dealing with symptoms of the other. I traveled to Washington, D.C., to…
Risk factors for pulmonary hypertension (PH) in people receiving maintenance hemodialysis, a blood-filtering treatment used when kidney function is severely reduced, appear to change with age, according to a single-center study in China. Diabetes was a risk factor for PH in patients 60 or older. In younger patients, PH…
Discussion
Tomorrow, a surgery is taking place, but for once, I won’t be the person counting back from 10 as they’re put to sleep. Instead, it’s my mother who will be undergoing a minor procedure. Fortunately, it’s low risk, but we’ve still had a lot to consider regarding her recovery, which…
Note: This story was updated May 28, 2026, to clarify the indications for which Cereno Scientific’s experimental therapies are being developed. The company is advancing CS1 as a potential treatment for pulmonary arterial hypertension. The first participant has been dosed in a clinical trial testing the pharmacological properties of…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
